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Background: Sexually transmitted infections (STIs) have been increasing among Australian Indigenous young people
for over two decades. Little is known about the association between alcohol and other drug use and sexual risk
behaviours and diagnosis of STIs among this population.
Methods: A cross-sectional, community based self-administered survey was conducted among young Aboriginal
people aged 16–29 years of age. Questionnaires included socio-demographic characteristics, knowledge, sexual risk
behaviours alcohol and other drug use and health service access including self-reported history of diagnosis with a STI.
Logistic regression models and population attributable risks were used to assess individual and population level
impacts of illicit drug use on high risk sexual behaviours and ever reported diagnosis of an STI.
Results: Of the 2877 participants, 2320 (81 %) identified as sexually active and were included in this study. More than
50 % of the study population reported that they had used at least one illicit drug in past year. Cannabis, ecstasy and
methamphetamines were the three most commonly used illicit drugs in the past year. The prevalence of self-reported
STI diagnosis was 25 %. Compared with people who did not report using illicit drugs, risky alcohol use and sexual
behaviours including inconsistent condom use, multiple sexual partners in the past year and sex with casual partners
were all significantly higher among illicit drug users. In adjusted analysis, participants who reported using illicit drugs
were significantly more likely to engage in sexual risk behaviours and to ever have been diagnosed with an STI.
Adjusted Odds Ratios ranged from 1.86 to 3.00 (males) and from 1.43 to 2.46 (females). At the population level, more
than 70 % of the STI diagnoses were attributed to illicit drug-use and sexual risk behaviours for males and females.
Conclusion: Illicit drug use in this population is relatively high compared to other similar aged populations in Australia.
Illicit drug use was associated with risky sexual behaviours and STI diagnoses among this study population. Developing
and implementing effective STI prevention strategies should include not only safe sex messages but also include drug
and alcohol harm reduction messages.
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In Australia, young Aboriginal and Torres Strait Islander
(hereafter Aboriginal) people are disproportionately repre-
sented in sexually transmissible infections (STI) notification
data [1]. Representing just 3 % of the total population, yet
accounting for 38 and 16 % of all gonorrhoea and chla-
mydia notifications in 2013, there remains an enormous
gap between Aboriginal and non-Indigenous Australians.
Further these rates have been disparate for over two
decades, despite many program and policy interventions
[1]. In addition to the high rates of STIs, previous studies
have reported a relatively higher use of licit and illicit drugs
such as alcohol, cannabis, ecstasy and methamphet-
amines among young Aboriginal people compared to
non-Indigenous Australians [2]. Strong correlations
between drug and alcohol use, and high risk sexual
behaviours have been previously reported such as
multiple/concurrent partners and infrequent condom
use [3–5]. Methamphetamine has been previously
reported to increase sexual pleasure and function and
as such is associated with higher sexual risk behaviour
and potential for STI including human immunodefi-
ciency virus (HIV) transmission [6].
While various risk factors have been identified and
associated with high risk sexual behaviours and STI
diagnosis, their individual and population level contribu-
tions have not been investigated among Aboriginal people
in Australia. In order to inform timely and effective STI
prevention responses, we examined the dynamics of illicit
drug and alcohol use and risky sexual behaviours. We par-
ticularly assessed their individual and population level
contributions on STI diagnoses in Aboriginal people aged
16–29 who participated in a community based survey of
sexual health and relationships.
Methods
Study design and sampling
A detailed description of the study population has been
described elsewhere [7]. Briefly, the study population were
Aboriginal women and men, aged 16–29 years, who were
recruited at 40 Aboriginal one or two day cultural and
sporting community events across Australia during the
period of 2011 and 2013. Convenience sampling was used
to recruit the study participants. The majority of events
were mainly community events including several cultural
celebrations (18/40), sports carnivals (15/40), annual
regional show days/weekends (5/40) or Aboriginal
community health events (2/40).
Study population
The study collected demographic characteristics, sexual
risk behaviour information including alcohol and other
drug use, knowledge and self-reported diagnosis of STI
from 2,877 individuals (59 % females and 41 % males).Of these, 2,320 (81 %) identified as being sexually active
and are included in this analysis.
Data collection
Questionnaires administered by peer workers on site. Con-
sented participants completed the questionnaire using
handheld personal digital assistants (PDAs). The PDAs
were loaded with a specialised program to administer the
prepared questionnaire and collect information in a de-
identified, secure format. Participants were expected to
read the questions and provide their responses by touching
the screen with a small stylus. Audio recordings of the
questionnaire were also available to the participants from
the device. The software programs used for questionnaire
design, survey administration, data collection and storage
were Questionnaire Development System Design Studio
(v2.6.1), HAPI (v2.6.1) and Warehouse Manager (v2.6.1)
from NOVA Research Company. Current study included
aboriginal men and women who were 16 to 29 years of age
and consented to complete the survey. Overall, 8 % of the
participants refused to complete the survey. Refusals were
defined as not willing to complete the survey after survey
collectors had explained the study to the participant. If an
individual refused to complete the survey, no further
information was collected and he/she was excluded
from the study. However, Survey collectors recorded
only the number refusals during set time periods at
each event to gauge an understanding of the proportion
of refusals overall for the study.
We focussed on factors previously identified as po-
tential determinants of sexual risk behaviour including
an STI diagnosis [7]: such as age (<20 years, 20–24 years,
and 25+ years), level of completed education (< high
school vs. high school or above), age at sexual debut
(<16 years vs. 16+ years old), sexual identity (heterosexual
vs. gay/bisexual); number of sexual partners in the past
year (3 or more vs. <3); and being drunk/high (yes vs. no)
at last sex as well as illicit drug use for the three most
commonly used drugs in the previous 12 months,
methamphetamine, ecstasy and cannabis. Other illicit
drugs were grouped and included cocaine, heroin,
petrol, fantasy, benzodiazepines, ketamine and acid
were also collected as (yes/no). Each illicit drug used
was categorized as a dichotomous measure. Condom
use was measured using several questions including
“How often did you use condoms in past year” (always
vs. not always) and “Did you use a condom at last sex?
(yes/no)”. Additional characteristics such as current
smoker (yes vs. no) and alcohol intake status (7+
drinks/week vs. vs <7) were also considered as potential
correlates of the primary outcome of interests. The
primary outcome variables were dichotomous measures
of (1) sexual risk behaviours (inconsistent condom use
and/or three or more sexual partners in past 12 months)
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reported ever being tested for any STI.
Statistical analysis
We used descriptive statistics (percentages) to characterise
the study population according to their total number of
illicit drugs used (more than once) in the last year. In this
analysis, we first created a “drug score” for each individual
by assigning a score of 1 (if illicit drugs were reported as
being used) and 0 (otherwise); after we added the scores
for each individual drug used, we re-categorized them
according to their final drug score: (0: no drug, 1: one
drug only, 2: two-drugs, 3: three-drugs and 4: four or
more drugs).
We formally assessed the influence of socio-demographic
characteristics; illicit drug use for the most commonly used
illicit drugs, namely, cannabis, ecstasy and methampheta-
mine, and alcohol use on engaging in sexual risk behaviours
and STI diagnosis separately.
For these analyses, sexual risk behaviour (yes vs. no)
was defined as individuals who reported at least 3 or
more sexual partners in the previous 12 months and not
using condom in last sex. Age adjusted logistic regres-
sion models were used to determine whether illicit drug
use was associated with sexual risk behaviours and a
self-reported previous STI diagnosis. Adjusted odds
ratios (aORs) and 95 % Confidence Intervals (CIs) are
presented for women and men separately.
We tested the fitness of the model using the Hosmere-
Lemeshow criteria [8]. The primary aim of this analysis
was to assess whether the combination of risk factors
under consideration could predict those at increased risk
of an STI diagnosis with accuracy and an acceptable
level of robustness.
We also calculated the population attributable risk
(PAR) so as to estimate the proportion of sexual risk be-
haviours and STI diagnosis that could have been avoided if
it was possible to modify some of the characteristics of the
study population [9]. PAR is used as other standard
statistical measures such as an odds ratio do not give
sufficient evidence regarding their potential impact on
disease occurrence. Briefly, PAR quantifies the population
level impact of a risk factor of interest on the primary out-
come of interest. The PAR is an epidemiological measure
originally formulated as a function of odds ratio (OR)
(from adjusted logistic regression) and the prevalence of
risk factors of interest when there is only one risk factor at
two levels (1 versus 0)
PAR ¼ p OR−1ð Þ




where s indexes the two strata determined by the value of
a risk factor. We generalized the PAR into a multifactorialsetting where there is more than one risk factor at mul-






s¼1ps ORs−1ð Þ þ 1
¼ 1− 1XS
s¼1psORs
where ORs and ps, s = 1,…, S, are the odds ratios and the
prevalence in the target population for the s being the
combination of the risk factors [9].
The above equation can be interpreted as the propor-
tion of the number of sexual risk behaviours and STI
diagnosis that can be reduced if all known risk factors
were eliminated or modified (at least theoretically) from
the target population.
The PAR reflects the difference between the expected
number of cases in the study population and the number
of cases expected if all subsets of the members in the
study population who were originally exposed to the
modifiable risk factor(s) had eliminated their exposure(s)
so that their odds ratios compared to the unexposed was
1, divided by the number of cases expected in the
original cohort.
For this analysis, illicit drug use and risky alcohol use
were all assumed to be modifiable risk factors. All of the
PAR models were adjusted for age as it was considered
to be a non-modifiable background risk factor. For the
STI diagnosis outcome, sexual risk factors including
inconsistent condom use and the number of recent
sexual partners were also assumed to be modifiable risk
factors. The PAR was estimated using adjusted odds ratios
for each individual risk factor and their various combina-
tions were calculated using logistic regression models.
Prevalences for combinations of risk factors were estimated
as multinomial probabilities among study participants at
each unique level. Based on the methodology described
above, gender-specific theoretical STI prevention strategies
can be investigated.
Analyses were performed using Stata 12.0 (College
Station, TX, USA) and SAS statistical software, version
9.3 (SAS Inc., Cary, NC, USA).
Results
Of the 2877 participants who completed the survey,
2320 (81 %) of them were identified as sexually active
(answered yes to ever had anal or vaginal sex) (40 and
60 % males and females respectively) and included in
our analysis. Overall 42 % of this study population were
aged between 16 and 20 years with over 50 % having less
than a completed high school education. A total of 1029
(44 %) reported using illicit drugs in the previous
12 months. Of these, 869 (84 %) reported using cannabis;
344 (33 %) and 296 (29 %) reported using ecstasy and
methamphetamine respectively in past year; 8 % (n = 83)
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12 months (data not shown). Cocaine use was reported by
11 % (n = 116) of illicit drug use participants and the least
reported drugs were Lysergic acid diethylamide (LSD)
(5 %), fantasy (4 %), benzodiazepines (2 %) and ketamine
(2 %) (data not shown).
Characteristics of the participants by patterns of drug-use
categories
Table 1 presents the characteristics of the study partici-
pants across the 5-drug use categories (none, 1-drug,
2-drugs, 3-drugs and 4+ drugs) for women and men sep-
arately. There were no significant differences found by
drug-use categories, by age group, nor sex. However there
was an increasing trend between sexual risk behaviours
and drug-use categories. Compared with women who did
not use illicit drugs in the previous 12 months, those who
reported using more drugs reported higher rates of not
using a condom at last sex (64.2 vs. 71.1, 72.3, 81.8 and
81.1 %, for no-drug to 4+ drugs respectively). Similarly
among men, an increasing trend of not using a condom at
last sex was associated with higher poly drug use (55.9 vs.
65.4, 65.9, 80 and 72.7 %, for no-drug to 4+ drugs respect-
ively). Higher proportions of people who used illicit drugs
reported being high or drunk at last sex compared to
those who did not use drugs [23.5 % (no-drug) vs. 31.4 %
(1-drug) – 55.4 % (4+ drugs) for women and [24.4 %
(no-drug) vs. 48.9 % (1-drug) to 68.2 % (4+ drugs)].
Among women who did not use illicit drugs in the previ-
ous 12 months compared with illicit drug users they were
less likely to have had sex with someone they just met
(casual partner) (6.9 vs. 8 % (1-drug) to 19.8 % (4+ drugs)),
and similarly among men (14.2 vs. 18.7 % (1-drug) to
30.7 % (4+ drugs)). Self-reported STI diagnosis were more
common among poly drug users compared to non-drug
users (21.3 % (1-drug) - 42.6 % (4 + drugs) vs. 14.1 %
(non-users) (women) and 27.7 % (1-drug) -52.4 % (4 +
drugs) vs. 21.7 % (non-users).
Correlates of high risk sexual and drug use behaviours
Table 2 presents the frequency distribution and adjusted
odds ratios for the risk factors stratified by sex. Older
age groups (20–24 years and 25+ years), early age at
sexual debut (<16 years old) and frequent alcohol intake
(>7 drinks per week) were significantly associated with
an increased prevalence of sexual risk behaviours in both
women and men. Participants who used cannabis, ec-
stasy and methamphetamine in the previous 12 months
also had significant correlates of sexual risk behaviours.
Among women adjusted odds ratios for sexual risk
behaviour among those who reported using cannabis
were (aOR: 1.94, 95 % CI: 1.48, 2.55); for ecstasy (aOR:
2.03, 95 % CI: 1.30, 3.18) and methamphetamines (aOR:
2.14, 95 % CI: 1.32, 3.48); and for men: aOR for cannabisuse was (aOR: 2.96, 95 % CI: 1.53, 3.05) for ecstasy
(aOR: 3.00, 95 % CI: 1.53, 3.05) and methamphetamines
(aOR: 2.25, 95 % CI: 1.33, 3.79). Smoking status was
associated with increased levels of high risk sexual
behaviours in males only; while less than a completed
high school education appeared to have a significant
impact on females only (aOR: 1.45, 95 % CI: 1.05, 2.00
and aOR: 1.38, 95 % CI: 1.08, 1.76 respectively).Correlates of STI diagnoses
Being of an older age group, identifying as gay or bisexual,
having three or more sexual partners in the past year and
being drunk or high at last sex were all associated with a
past STI diagnosis in men. In addition, cannabis, ecstasy
and methamphetamine use were identified as significant
correlates of increased prevalence of a self-reported STI
diagnosis [(aOR: 1.86, 95 % CI: 1.24, 2.79); (aOR: 2.98,
95 % CI: 1.92, 4.62); (aOR: 2.93, 95 % CI: 1.84, 4.67)]
respectively. Most of the risk factors identified as signifi-
cant correlates for STI diagnosis for males were also identi-
fied among females. Particularly illicit drug use and being
drunk or high at last sex showed strong associations with a
self-reported previous STI diagnosis. Among women who
reported using illicit drugs [(aOR: 1.94, 95 % CI: 1.48,
2.55); (aOR: 2.03, 95 % CI: 1.30, 3.18); (aOR: 2.00, 95 % CI:
1.48, 2.65) for cannabis, ecstasy and methamphetamine
respectively were found. Early sexual debut (<16 years) was
found to be a significant predictor of a previous STI
diagnosis among females only.Population level impacts of risk factors on high risk
behaviours
In sex-specific analysis (Table 3), cannabis use was asso-
ciated with the highest PAR compared to ecstasy and
methamphetamines in both women and men; 32 %
(95 % CI: 25, 39 %) and 24 % (95 % CI: 20, 29 %) of the
high risk sexual behaviours were attributed to cannabis
use for men and women respectively. Relatively high
prevalence and odds ratios were responsible for this high
impact [36 and 40 % (prevalences); 1.94 and 2.16 (odds
ratios) for women and men respectively]. Approximately
one third of sexual risk behaviours were associated with
alcohol intake (>7 drinks/week) among males; being
drunk or high at last sex was associated with the high-
est PAR with 34 % among males; while 21 % of the
high risk behaviours were associated with this factor
among females.
The combined impact of all drug related factors,
namely cannabis, ecstasy, cocaine, associated with 45 %
(95 % CI: 36, 51 %) and 30 % (95 % CI: 24, 35 %) of the
high risk sexual behaviours among men and women
respectively. When these three-drug related factors were
combined with the alcohol related factors, PAR increased
Table 1 Characteristics of the sexually active study population (n = 2320) by poly-drugs (including methamphetamine, ecstasy, cannabis, cocaine, heroin, petrol, fantasy, benzo,
ketamine, LSD-acid
Males (n = 939) Females (n = 1381)
No drug
N = 479 (51 %)
1-drug
N = 237 (24 %)
2-drugs
N = 85 (9 %)
3-drugs
N = 50 (5 %)
4+ drugs












16–19 years 219 (45.72) 95 (40.08) 32 (37.65) 18 (36.00) 31 (35.23) 287 (35.34) 120 (34.29) 34 (33.66) 14 (31.82) 21 (28.38)
20–24 years 157 (32.78) 75 (31.65) 30 (35.29) 15 (30.00) 31 (35.23) 264 (32.51) 128 (36.57) 35 (34.65) 17 (38.64) 31 (41.89)
25–29 years 103 (21.50) 67 (28.27) 23 (27.06) 17 (34.00) 26 (29.55) 261 (32.14) 102 (29.14) 32 (31.68) 13 (29.55) 22 (29.73)
Education
<high school 236 (49.27) 144 (60.76) 51 (60.00) 24 (48.00) 54 (49.27) 236 (49.27) 144 (60.76) 51 (60.00) 24 (48.00) 54 (61.36)
Age at sex
<16 years 372 (77.66) 191 (80.59) 69 (81.18) 41 (82.00) 68 (77.27) 502 (61.82) 248 (70.86) 76 (75.25) 36 (81.82) 58 (78.38)
Condom used in last sex
No 268 (55.95) 155 (65.40) 56 (65.88) 40 (80.00) 64 (72.73) 521 (64.16) 249 (71.14) 73 (72.28) 36 (81.82) 60 (81.08)
Sexual identity
Gay/Bisexual 18 (3.76) 18 (7.59) 7 (8.24) 4 (8.00) 20 (22.73) 16 (1.97) 13 (3.71) 5 (4.95) 4 (9.09) 3 (4.05)
Last person sex with
Boyfriend/girlfriend 319 (66.60) 128 (54.01) 39 (45.88) 19 (38.00) 36 (40.91) 567 (69.83) 238 (68.00) 52 (51.49) 26 (59.09) 41 (55.41)
Someone just met 68 (14.20) 45 (18.66) 24 (28.24) 11 (22.00) 27 (30.68) 56 (6.90) 28 (8.00) 16 (15.84) 8 (18.18) 8 (10.81)
Other 92 (19.21) 64 (27.00) 22 (25.88) 20 (40.00) 25 (28.41) 189 (23.28) 84 (24.00) 33 (32.67) 10 (22.73) 15 (33.78)
Number of sexual partners
3+ 153 (31.94) 96 (40.51) 46 (54.12) 24 (48.00) 49 (55.68) 116 (14.29) 88 (25.14) 38 (37.62) 15 (34.09) 34 (45.95)
Current smoker
Yes 122 (25.47) 140 (59.07) 52 (61.18) 31 (62.00) 65 (73.86) 265 (32.64) 216 (61.71) 64 (63.37) 33 (75.00) 56 (75.68)
Alcohol intake
>7+ drinks/week 214 (44.68) 128 (54.01) 50 (58.82) 26 (52.00) 46 (52.27) 272 (33.50) 159 (45.43) 42 (41.58) 14 (31.82) 25 (33.78)
Drunk/high last sex
Yes 117 (24.43) 116 (48.95) 40 (47.06) 28 (56.00) 60 (68.18) 191 (23.52) 110 (31.43) 50 (49.50) 20 (45.45) 41 (55.41)
Diagnosed with STIa















Table 2 Factors associated with increased prevalence of high risk behavioursa (condom not used in last sex and/or 3+ sexual
partners in past 12 months): b age adjusted, among testers
Males Females
High risk sexual




behaviours (n = 1381)
STI diagnosisb
(n = 1017)
% Adjusted ORb p-value Adjusted ORb p-value % Adjusted ORb p-value Adjusted ORb p-value
Age groups
16–19 years 42 % 1 1 35 % 1 1
20–24 years 33 % 1.74 (1.21,2.50) 0.003 1.12 (0.66,1.90) 0.680 34 % 1.68 (1.27,2.23) <0.001 1.39 (0.96,2.01) 0.082
25+ years 25 % 2.06 (1.37, 3.11) 0.001 2.12 (1.27,3.52) 0.004 31 % 2.61 (1.91,3.56) <0.001 1.60 (1.11,2.32) 0.012
Education
< high school 46 % 1.08 (0.78,1.49) 0.637 1.18 (0.78,1.78) 0.444 49 % 1.38 (1.08,1.76) 0.011 1.40 (1.05,1.86) 0.022
Sexual identity
Gay/Bisexual 7 % 1.67 (0.81,3.46) 0.165 2.73 (1.52,4.90) 0.001 3 % 1.26 (0.57,2.78) 0.570 1.02 (0.47,2.22) 0.968
Age at sexual debut
<16 years old 79 % 1.89 (1.28,2.79) 0.001 0.98 (0.60,1.60) 0.922 67 % 2.00 (1.53, 2.58) <0.001 1.60 (1.16,2.18) 0.004
Condom used last sex
No 62 % – – 1.54 (0.98,2.40) 0.058 68 % – – 1.96 (1.39,2.77) <0.001
Sex partners in past year
3 or more 39 % – – 1.66 (1.11,2.49) 0.013 21 % – – 1.78 (1.29,2.45) <0.001
Current smoker
Yes 44 % 1.45 (1.05,2.00) 0.025 1.41 (0.94,2.11) 0.098 54 % 1.16 (0.91,1.49) 0.229 1.16 (0.88,1.54) 0.300
Alcohol intake
>7+ 49 % 1.85 (1.34,2.53) <0.001 1.04 (0.69,1.55) 0.857 37 % 1.44 (1.11,1.87) 0.006 0.98 (0.74,1.31) 0.912
Drunk/high last sex
Yes 63 % 2.39 (1.68, 3.40) <0.001 2.27 (1.51,3.42) <0.001 57 % 2.00 (1.48,2.65) <0.001 1.74 (1.29,2.35) <0.001
Methamphetamine used
Yes 17 % 2.25 (1.33,3.79) 0.002 2.93 (1.84,4.67) <0.001 10 % 2.14 (1.32,3.48) 0.002 1.80 (1.16,2.80) 0.009
Ecstasy used
Yes 20 % 3.00 (1.79,5.03) <0.001 2.98 (1.92,4.62) <0.001 12 % 2.03 (1.30,3.18) 0.002 2.46 (1.63,3.70) <0.001
Cannabis used
Yes 40 % 2.16 (1.53,3.05) <0.001 1.86 (1.24,2.79) 0.003 36 % 1.94 (1.48,2.55) <0.001 1.43 (1.07,1.91) <0.001
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for females and males respectively (Table 3).
Population level impacts of risk factors on STI diagnosis
Individual and combined level impacts of drug, alcohol
and high risk sexual behaviour factors on self-reported
STI diagnosis are presented in Table 3 for men and
women separately. High risk sexual behaviours, namely,
not using a condom at last sex and having 3 or more
sexual partners in the past year were considered together
and appeared to have the largest impact on STI diagno-
sis in males and females (PAR: 72, 95 % CI: 62, 80 % and
PAR: 40, 95 % CI: 30, 49 % for males and females).
Among men, the population level impacts of cannabis,
ecstasy, methamphetamine use on STI diagnosis were
estimated to be 27, 30 and 28 % respectively. When allthese drugs were combined, PAR increased to 43 %
(95 % CI: 34, 51 %); while these drugs were collectively
responsible for 20 % (95 % CI: 15 %, 25 %) of all the
diagnoses among females. Finally, our data suggested
that 74 % (95 % CI: 66 %, 80 %) of the all the STI diag-
noses were attributed to the seven modifiable risk factors
among males. This proportion was 70 % (95 % CI: 63,
75 %) among females. Goodness of fit measures of the
adjusted models were ranged from 0.091–0.989 (for
males) and 0.423–0.612 (for females) for both primary
outcome variables.
Discussion
To our knowledge, this is the first study to report indi-
vidual and population level impacts of combinations of
risk factors including alcohol and illicit drug use on
Table 3 Population level impact of (potentially) modifiable risk factors
Potentially modifying risk factors High risk sexual behavioursa STI Diagnosisb
PAR% (95 % CI) PAR% (95 % CI)
Drug & alcohol related Male Female Male Female
Cannabis use 32 % (25, 39 %) 24 % (20, 29 %) 27 % (20, 36 %) 13 % (10, 17 %)
Ecstasy use 29 % (22, 37 %) 11 % (9, 14 %) 30 % (25 37 %) 13 % (10, 16 %)
Methamphetamine use 20 % (14, 25 %) 11 % (8, 14 %) 28 % (22, 34 %) 7 % (5, 10 %)
Alcohol intake (7+/week) 30 % (23, 36 %) 14 % (11, 18 %) – –
Drunk/high last sex 34 % (28, 40 %) 21 (17, 25 %) 31 % (24, 39 %) 17 % (13, 21 %)
High risk sexual behavioursa
No condom use in last sex – – 72 % (62, 80 %) 40 % (30, 49 %)
+3 or more sexual partnersd
Modifying drug use
Cannabis use
+ Ecstasy use 45 % (36, 51 %) 30 % (24, 35 %) 43 % (34, 51 %) 20 % (15, 25 %)
+ Methamphetamine use
Modifying drug/alcohol
+ high risk sexual behaviours†
All drug related
+ Alcohol relatedc 76 % (71, 80 %) 70 % (65, 73 %) 74 % (66, 80 %) 70 % (63, 75 %)
+ No condom use last sex
+3 or more sexual partnersd
anot used condom in last sex, and/or 3+ sexual partners past 12 months; bamong testers
cincluding only drunk/high in last sex for the “STI diagnosis”; dpast 12 months
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STI diagnosis among young Aboriginal people. This
study highlights significant interplay between illicit drug
use, sexual risk behaviours and self-reported past STI
diagnosis among this population with the finding that
the majority of risky sexual behaviours and past STI
diagnosis were associated to drug and alcohol use in
both women and men. The three most commonly used
illicit drugs by this study population, (cannabis, ecstasy
and methamphetamines), collectively accounted for 45
and 30 % of the high risk behaviours among males and
females respectively. Together alcohol and illicit drugs
showed the strongest associations with risky sexual
behaviours. This suggests that reducing alcohol and
illicit drug use would make a significant impact on STI
transmission in this population.
Assessing the impact of individual risk factors for STIs
has important implications for prevention policy as well
as clinical practice. Previous studies have shown the link
between STI diagnosis, and sexual risk behaviour and
our study concurs with these findings [3, 10–14]. Cur-
rently in Australia the two professional fields of health
prevention of alcohol and other drugs and sexual health
are often delivered separately and rarely is there cross
over in the workforce; however our data show many rea-
sons why these two fields should be merged or workmore closely with each other. Models of care should be
explored such as testing for STIs, including HIV as well
as other blood borne viruses such as hepatitis B and C.
Further characterizing, identifying and targeting indi-
viduals with both alcohol and other drug use issues
and who engage in sexual health risk behaviour will
most likely play a significant role in the trajectory of
diagnosis with sexually transmitted infections. It is
now accepted that illicit drug users routinely engage
in high-risk sexual behaviours that put them at an
increased risk of contracting sexually transmitted
infections including HIV [15, 16].
Our study also shows the impact that alcohol and
other drug use has at a population level on sexual risk
behaviours. In our study population, relatively risky alco-
hol misuse was found to be associated with risky sexual
behaviours at a population level (PAR%: 50 and 40 % for
males and females respectively) as well as having strong
associations with a past STI diagnosis (aOR: 1.68 and
1.69 for males and females respectively). While this field
has been rarely investigated in Australia among young
Aboriginal people much more work is required to assess
the impact of alcohol restrictions on STI and sexual risk
behaviour. A study of alcohol restrictions in the Kimberley
region witnessed a decrease in STI notifications [17].
Much more work is required to assess this impact.
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self-reported STI diagnoses were associated with seven
modifiable risk factors among males; while 60 % of the
self-reported STI diagnoses were attributed to these
modifiable factors when the study population is restricted
to females only. The difference between the males and
females were due to the differences in the prevalences of
the drug/alcohol related factors; particularly metham-
phetamine, ecstasy use, frequent alcohol intake and being
drunk at last sex were more common among males
compared to the females. In terms of high risk sexual
behaviours, lack of condom use in last sex was slightly
higher among females (68 vs. 62 %) while having higher
number of sexual partners past 12 months almost doubled
among males compared to females (39 vs. 21 %).
Consistent with these estimates, more than 70 % of
the self-reported STI diagnoses were attributed to the
high risk sexual behaviours (namely lack of condom
use in last sex and higher number of sexual partners)
among males compared to 40 % among females.
The PAR findings for the self-reported past STI diag-
noses suggest that among males almost three quarters of
these diagnoses (72 %) could be avoided by reducing the
high risk sexual behaviours (i.e. increasing condom use
and decreasing number of sexual partners); while these
factors collectively accounted for 40 % of the diagnoses
among the females.
This study has several limitations; therefore the results
should be interpreted accordingly. First the representative-
ness of participants recruited from community events may
be questionable as those who attend these events may
have different characteristics than those who do not; par-
ticularly the way that they are connected to their commu-
nities, their knowledge regarding sexually transmitted
infections, and use of health services compared to other
young Aboriginal individuals. Nevertheless, we are not
aware of another means of recruiting a large, diverse
young Aboriginal people as strategies based on household
or telephone recruiting may potentially under-represent
Aboriginal individuals. However the proportion of partici-
pants who self-reported ever having an STI diagnosis is
consistent with available epidemiological evidence on STI
positivity in the population [1].
Current study was designed as a cross-sectional survey;
therefore it shares the same limitations of these types of
study designs such as lack of temporal associations between
exposure and outcomes of interest. Testing, diagnosis and
behavioural data were all collected by self-report and may
be subject to both recall bias and measurement error. The
main limitation of the study however is the lack of bio-
logical testing results for previous STI diagnoses. However,
we did find strong associations between participants who
used illicit drugs and alcohol with risky sexual behaviours
compared to those who did not use alcohol and illicitdrugs. Similarly we found strong association between those
who used alcohol and illicit drugs and a previous self-
reported STI diagnoses compared to those who had not
used alcohol at risky levels or illicit drugs. Therefore,
we conducted the analyses in two-stages: first we iden-
tified the factors associated with risky sexual behaviours
(e.g. combination of lack of condom use and higher
number of sexual partners); and secondly, we assessed
the associations between the high risk behaviours along
with other socio-demographic factors with a past self-
reported STI diagnoses. Our results indicate that the
majority of the factors associated with high risk sexual
behaviours were also associated with high prevalence of
past STI diagnosis.
There is an urgent need to focus on new STI prevention
intervention strategies that will not only address the safe
sex behaviour of young Aboriginal people, but also encour-
age reducing illicit drug use and risky alcohol intake.
Conclusion
The impact of risk factors for a disease at a population
level has important implications for prevention policy and
practice. In our study we have shown that the majority of
the high risk sexual behaviours and STI diagnoses were
associated to using illicit drug use and risky alcohol use.
The PAR findings suggest that the largest number of STIs
could be avoided by reducing high risk sexual behaviours
as well as drug and alcohol intake.
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